U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07397936) titled 'Rebamipide Versus Diquafosol and Cyclosporine for Perioperative Dry Eye in Cataract Surgery' on Feb. 02.
Brief Summary: The goal of this clinical trial is to compare the efficacy of 2% rebamipide monotherapy versus a combination therapy of 3% diquafosol and 0.05% cyclosporine for the management of dry eye disease in patients undergoing cataract surgery. It will also evaluate the safety and ocular surface stability effects of these treatments during the perioperative period.
The main questions it aims to answer are:
Does rebamipide monotherapy maintain tear film breakup time (TBUT) and prevent corneal damage as effectively as the c...